Multiplexed CRISPR-based methods for pathogen nucleic acid detection
- 20 May 2023
- journal article
- research article
- Published by Elsevier in Current Opinion in Biomedical Engineering
- Vol. 27
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences
- National Institutes of Health (T32GM007388)
This publication has 47 references indexed in Scilit:
- Field-deployable viral diagnostics using CRISPR-Cas13Science, 2018
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience, 2018
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6Science, 2018
- CRISPR-Cas12a-assisted nucleic acid detectionCell Discovery, 2018
- Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnosticsNucleic Acids Research, 2018
- Nucleic acid detection with CRISPR-Cas13a/C2c2Science, 2017
- Clinical and biological insights from viral genome sequencingNature Reviews Microbiology, 2017
- Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detectionNature, 2016
- The use of next generation sequencing in the diagnosis and typing of respiratory infectionsJournal of Clinical Virology, 2015
- Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencingNature, 1993